RxDoctor Payments Data

Nomen Azeem, MD

Interventional Pain Medicine · Riverview, FLNPI 1255594206

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 18.1%. Reporting peaked in 2019 at $169,756 and has fallen 81.8% since, to $30,969 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$650,199in general payments, 2019–2025

Across 1,937 payments — averaging $335.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertiflex, Inc.$118K
  • Spinal Simplicity, LLC$112K
  • Medtronic$109K
  • Abbott$109K
  • Painteq LLC$84K
  • Boston Scientific$48K
  • plus $71K from 37 others
$38,344in research payments, 2019–2025

Across 27 payments — averaging $1420.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Painteq LLC$24K
  • Mesoblast, Inc.$15K
$7,796in ownership & investment interests, 2019–2025

Across 3 payments — averaging $2598.50 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Simplicity, LLC$8K

What the payments were for

  • Consulting fees$201,45831%
  • Speaking & faculty fees$258,80940%
  • Travel & lodging$81,75613%
  • Food & beverage$67,04510%
  • Education$41,0826%
  • Entertainment$490%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$650,199 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$197,140
Medicare patients
179
Services billed
1,812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe11$9,967
BelbucaBuprenorphine Hcl12$6,707
Pregabalin60$2,167
Chlorzoxazone41$1,484
Diclofenac Sodium67$715
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$691
Gabapentin69$557
Methylprednisolone52$373
Methocarbamol35$338
Celecoxib24$221
Tizanidine Hcl43$178
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim49$125

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Riverview

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →